In recent years, multiple myeloma has changed its face. The lengthening of survival and the succession of treatment lines have brought it closer and closer to a chronic disease. "The myeloma today is a pathology with which patients live together for several years and therefore requires long therapeutic paths, which can vary in intensity," explains Fabrizio Accardi, medical director of the UO of Oncoematology of the Hospital Hospitals Reunited Vi…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
In recent years, multiple myeloma has changed its face. The lengthening of survival and the succession of treatment lines have brought it closer and closer to a chronic disease. "The myeloma today is a pathology with which patients live together for several years and therefore requires long therapeutic paths, which can vary in intensity," explains Fabrizio Accardi, medical director of the UO of Oncoematology of the Hospital Hospitals Reunited Vi…